Use of Adrenocorticotropic Hormone in Ophthalmology
- 1 November 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 36 (9) , 661-667
Abstract
The ability of the adrenocorticotropic hormone (ACTH) to induce steroidogenesis and upregulate anti-inflammatory processes has long been known. More recently, however, extrasteroidal mechanisms, through which ACTH exerts anti-inflammatory processes, have been described. This has renewed hope that ACTH can combat inflammatory conditions even when resistant to steroids. This review article summarizes the literature on the use of ACTH in ocular disease. Unfortunately, much of the data regarding the clinical utility of ACTH are outdated, with many studies published in the 1950s and 1960s. Many of these older studies are inconsistent or incomplete with their reporting, making it difficult to ascertain the meaning of the outcomes. Despite the limitations, 2 important trends are evident. First, when used to treat an inflammatory disease, ACTH can be effective at decreasing or eliminating ocular inflammation, even in a refractory disease resistant to multiple treatment modalities. Second, adverse effects of ACTH are rare and are most likely to be reported with relatively high doses of ACTH therapy. Taken as a whole, these studies offer initial promising data that ACTH may be a safe and effective alternative in refractory ocular inflammatory disease. However, they highlight an important lack of prospective data to more rigorously understand the true safety and efficacy of this therapy.Keywords
This publication has 55 references indexed in Scilit:
- Following EAU Recovery There Is an Associated MC5r-Dependent APC Induction of Regulatory Immunity in the SpleenInvestigative Ophthalmology & Visual Science, 2011
- Immunosuppressive activity of a novel peptide analog of alpha-melanocyte stimulating hormone (α-MSH) in experimental autoimmune uveitisJournal of Neuroimmunology, 2011
- A look at autoimmunity and inflammation in the eyeJournal of Clinical Investigation, 2010
- Injection of an alpha-melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitisInternational Immunopharmacology, 2009
- Ocular immune privilegeEye, 2009
- Mechanism related to reduction of intraocular pressure by melanocortins in rabbitsBritish Journal of Ophthalmology, 2000
- Neuropeptide Regulation of Immunity: The Immunosuppressive Activity of Alpha‐Melanocyte‐Stimulating Hormone (α‐MSH)Annals of the New York Academy of Sciences, 2000
- Signal transduction through NF-κBImmunology Today, 1998
- Structure, Regulation and Function of NF-kappaBAnnual Review of Cell Biology, 1994
- ACTH AND KERATOCONJUNCTIVITIS SICCAActa Ophthalmologica, 1952